Calumet Beheer
Beheer criteriumcontroles 2/4
De CEO Calumet is Louis Borgmann, benoemd in Jul2024, heeft een ambtstermijn van 2.17 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 6.80M, bestaande uit 14% salaris en 86% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.3% van de aandelen van het bedrijf, ter waarde $ 15.30M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 4.1 jaar en 2.2 jaar.
Belangrijke informatie
Louis Borgmann
Algemeen directeur
US$6.8m
Totale compensatie
| Percentage CEO-salaris | 13.97% |
| Dienstverband CEO | 2.2yrs |
| Eigendom CEO | 0.3% |
| Management gemiddelde ambtstermijn | 4.1yrs |
| Gemiddelde ambtstermijn bestuur | 2.2yrs |
Recente managementupdates
Recent updates
Narratiefupdate • Sep 17
CLMT: Expanded Credit Capacity And EPA Relief Will Support Future Upside
Analysts have raised their fair value estimate for Calumet from $60.00 to $75.00, citing updated assumptions for the discount rate, revenue growth, profit margin and future P/E, which they view as better reflecting the stock's risk and earnings potential. What’s in the News for Calumet Calumet amended its existing asset based loan facility, increasing total commitments to US$600 million, led by Bank of America.
Narratiefupdate • Sep 03
CLMT: SAF Expansion And Legal Risks Will Shape Earnings Repricing Prospects
Analysts have raised their price target for Calumet from $38.80 to $53.40, citing updated assumptions that combine a lower discount rate and P/E multiple with revised expectations for revenue growth and profit margins. What's in the News for Calumet Montana Renewables, a Calumet, Inc.Narratiefupdate • Aug 13
CLMT: Strong Q2 Execution And Margin Outlook Will Drive Future Upside
Analysts have kept their $60.00 price target for Calumet unchanged, citing a slightly lower discount rate, more moderate revenue growth assumptions, a modestly higher profit margin outlook, and a reduced future P/E multiple as the key factors in their updated model. What's in the News for Calumet Calumet reported Q2 CY2026 revenue of $1.45b, which was above Wall Street expectations, with sales up 40.8% year on year.Seeking Alpha • Aug 12
Calumet Is Quietly Ramping Up
Summary Calumet delivered a strong Q2, with adjusted EBITDA of $159M versus $116M estimates, driven by robust Specialty Brands performance and early MaxSAF production at MRL. MRL's SAF production ramp is slower than planned, but cash flow remains strong, enabling rapid debt paydown and supporting over $1/share per month in free cash generation. Valuation updates reflect higher cash generation, with a sum-of-the-parts equity value estimate of $71.5/share, factoring in conservative EBITDA and expansion upside. Key risks include crack spreads, RD margins, and execution on expansion, but substantial cash flow and deleveraging provide meaningful downside protection. Read the full article on Seeking AlphaAnalyse-artikel • Aug 12
Calumet, Inc. (NASDAQ:CLMT) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates
Shareholders of Calumet, Inc. ( NASDAQ:CLMT ) will be pleased this week, given that the stock price is up 11% to...
Narratiefupdate • Jul 30
CLMT: Compressed Future P/E Assumptions Will Restrain Returns Despite Strong 2024 Rally
Analysts have lifted their price target for Calumet to $26 from $25, citing updated assumptions for discount rates, revenue growth, profit margins, and future P/E expectations in their valuation work. What's in the News for Calumet Calumet, Inc.Narratiefupdate • Jul 16
CLMT: Balance Sheet Deleveraging And Earnings Repricing Will Shape Forward Returns
The analyst price target on Calumet has been revised from $23.45 to $38.80. Analysts point to updated assumptions around revenue growth, profit margins, discount rate, and future P/E to support the higher valuation.Narratiefupdate • Jul 02
CLMT: Lower Discount Rate And Stronger Margins Will Support Future Upside
Analysts have kept their $60.00 price target for Calumet unchanged, with small adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions supporting a steady view of the stock's valuation. What’s in the News for Calumet No recent Calumet company news or key developments were identified in the provided sources.Analyse-artikel • Jun 19
Calumet (CLMT) Stock Could Be 39.2% Overvalued After Oil Price Weakness
Oil’s latest slide, following the Iran peace deal and weaker Brent and WTI prices, has fed through to Calumet (CLMT). The stock has dropped 2.7% as investors reassess energy related revenue expectations. See our latest analysis for Calumet. Despite the latest pullback, Calumet’s recent share price performance has been strong. The 90 day share price return is 16.41% and the year to date share price return is 66.96%, while the 1 year total shareholder return is 98.66%. If you are reassessing...Narratiefupdate • Jun 18
CLMT: High Debt Risks Will Shape Future Stock Performance
Analysts have maintained their $60.00 price target on Calumet, incorporating updated assumptions that include a revenue growth rate of 18.01%, a profit margin of 1.92%, and a higher future P/E of about 49.71x to support the revised view. What’s in the News for Calumet Recent commentary highlights that Calumet stock has climbed to a new 52-week high, following a share price move of 85.6% over the past six months, according to a feature titled "3 Reasons CLMT is Risky and 1 Stock to Buy Instead".Narratiefupdate • Jun 04
CLMT: Shreveport Recovery And Premium SAF Contracts Will Support Bullish Case
Analysts have maintained their $60.00 price target for Calumet, citing updated assumptions that now include a slightly higher discount rate, a shift to modestly declining revenue growth, a small improvement in expected profit margins, and a marginally higher future P/E multiple. What's in the News Calumet reported that the Montana Renewables MaxSAF 150 expansion is complete, with sustainable aviation fuel volumes expected to be four to five times prior levels, according to the Q1 2026 earnings transcript.Narratiefupdate • May 14
CLMT: Shreveport Outage And Elevated Future P/E Will Pressure Returns
Analysts now hold Calumet's fair value steady at $25.00, with updated assumptions around discount rate, revenue growth, profit margins and future P/E shaping a more refined view of the stock's risk and earnings potential, rather than a change in the headline price target. What's in the News Calumet reported an operational update for the first quarter of 2026, highlighting unplanned maintenance at its Shreveport facility after organic chlorides were found in feedstock tanks (Key Developments).Narratiefupdate • Apr 30
CLMT: Shreveport Restart And Higher Margin Outlook Will Support Bullish Case
Analysts have adjusted their price target on Calumet to $60.00. The latest update reflects revised views on discount rate, revenue growth, profit margins and future P/E assumptions.Narratiefupdate • Apr 15
CLMT: Shreveport Recovery And Improved Outlook Will Support Higher Future P/E
Analysts have lifted their fair value estimate for Calumet from $33.00 to $60.00, reflecting updated assumptions around discount rates, revenue growth, profit margins, and a higher future P/E multiple. What's in the News Calumet reported an operational update for the first quarter of 2026 after identifying organic chlorides in feedstock tanks at its Shreveport facility.Narratiefupdate • Apr 01
CLMT: Projected 2025 Losses And Rich P/E Will Pressure Future Returns
Analysts have kept their Calumet price target at $25.00, citing a slightly lower discount rate, more measured expectations for revenue growth and profit margins, and a higher assumed future P/E multiple as key inputs behind the unchanged valuation. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million based on preliminary data (Key Developments).Narratiefupdate • Mar 18
CLMT: Expected 2025 Losses Will Continue To Weigh On Returns
Analysts have raised their price target on Calumet from $19.00 to $25.00 per share, citing updated assumptions that include a lower discount rate, revised revenue growth expectations, higher profit margin estimates, and an adjusted future P/E multiple. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million (Key Developments).Narratiefupdate • Mar 04
CLMT: Lower Margin Assumptions And Expected 2025 Losses Will Restrain Returns
Narrative Update on Calumet The analyst fair value estimate for Calumet has been reset from $13.25 to $19.00. Analysts point to updated assumptions around discount rates, revenue growth, profit margins, and future P/E as key drivers of the new target range.Narratiefupdate • Feb 18
CLMT: Expected 2025 Net Loss Will Sustain Bearish Equity Repricing
Analysts have nudged their price target on Calumet up by $0.80 to $23.45, reflecting updated assumptions around discount rates, profit margins and future P/E expectations. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, based on preliminary data (Key Developments).Analyse-artikel • Feb 05
Calumet, Inc. (NASDAQ:CLMT) Stock Rockets 26% But Many Are Still Ignoring The Company
Calumet, Inc. ( NASDAQ:CLMT ) shareholders have had their patience rewarded with a 26% share price jump in the last...Narratiefupdate • Feb 03
CLMT: Future Loss Guidance And Production Trends Will Support Fair Pricing
Analysts have raised their fair value estimate for Calumet from $21.45 to $22.65, citing updated assumptions around discount rates, revenue growth, profit margins and a future P/E of about 31.81x. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range of $69.0 million to $12.0 million based on preliminary data (Key Developments).Narratiefupdate • Jan 20
CLMT: Future Loss Guidance And Steady Production Will Support Fair Pricing
Analysts have kept their fair value estimate for Calumet steady at US$21.45, with only small tweaks to inputs such as the discount rate, revenue growth, profit margin and future P/E assumptions driving this unchanged price target. What's in the News Calumet issued earnings guidance for the year ending December 31, 2025, indicating an expected net loss in a range between $69.0 million and $12.0 million, based on preliminary data (Key Developments).Narratiefupdate • Jan 06
CLMT: Lower Margin Outlook Will Restrain Returns Despite Higher Production
Analysts have revised their price target on Calumet to US$13.25 from US$13.25, citing updated assumptions around discount rates, revenue growth, profit margins and future P/E that reshape how they view the balance between the company’s earnings potential and the risk investors are taking on. What's in the News Calumet issued earnings guidance for the year ended December 31, 2025, indicating an expected net loss in a range of US$69.0 million to US$12.0 million, based on preliminary data (company guidance).Narratiefupdate • Dec 17
CLMT: Softer Margins And Slower Revenue Expansion Will Limit Upside Potential
Analysts have modestly trimmed their price target on Calumet to $13.25. This reflects slightly lower expectations for revenue growth and profit margins, even as a reduced discount rate and a marginally higher future P/E multiple continue to support the valuation.Narratiefupdate • Dec 03
CLMT: Future Profit Margins Will Improve While Shares Remain Fairly Valued
Analysts have nudged their price target on Calumet shares higher to reflect modestly improved discount rate and valuation assumptions, and now see fair value as essentially unchanged near 21.45 dollars despite slightly more favorable risk and earnings profiles. What's in the News Reported third quarter 2025 total facility production of 88,668 bpd, up from 83,305 bpd in the prior year period (company operating results announcement).Narratiefupdate • Nov 19
CLMT: Future Profit Margins Will Improve With Lower RIN Liabilities
Analysts have raised their price target for Calumet from $20.25 to $21.45, citing improved revenue growth projections and greater profit margin expectations as key drivers behind the updated valuation. What's in the News Calumet reported a rise in total facility production to 88,668 barrels per day for the third quarter of 2025, up from 83,305 barrels per day during the same period last year (Announcement of Operating Results).Narratiefupdate • Nov 05
CLMT: Future Outlook Balances EPA Exemptions With Reduced RIN Liabilities
Analysts have raised their price target for Calumet from $19.25 to $20.25, citing improved margin expectations and a lower perceived discount rate, even though growth forecasts have been slightly reduced. What's in the News Calumet received an update from the EPA confirming that all of its small refinery exemption petitions filed from 2019 through 2024 have been granted either full or partial exemptions (Key Developments).Narratiefupdate • Oct 22
Analysts Lift Calumet Price Target After EPA Exemptions and Stable Margin Outlook
Narrative Update on Calumet: Analyst Price Target Revision Analysts have slightly raised their fair value estimate for Calumet from $19.05 to $19.25 per share, citing minor improvements in discount rate assumptions and a stable outlook for profit margins. What's in the News Calumet received full or partial exemptions from the U.S. Environmental Protection Agency (EPA) for every small refinery exemption petition filed between 2019 and 2024.Narratiefupdate • Oct 08
Renewable Trends And Specialties Will Shape Future Markets
Analysts have maintained their price target for Calumet at $19.05. They cite only minor adjustments to discount rate and valuation assumptions that do not materially alter their outlook for the company.Narratiefupdate • Sep 24
Renewable Trends And Specialties Will Shape Future Markets
Calumet’s valuation outlook remains stable, with both the discount rate and future P/E changing only marginally, resulting in an unchanged consensus price target of $19.05. What's in the News Calumet received full or partial EPA exemptions on all small refinery petitions from 2019–2024, reducing its accrued RIN liability from 396 million to 89 million RINs. The company was added to multiple Russell indexes, including Russell 2000, 2500, 3000, and their respective growth and value variants, increasing its visibility to index funds and institutional investors.Narratiefupdate • Sep 09
Renewable Trends And Specialties Will Shape Future Markets
Calumet’s valuation outlook remains steady, with both the discount rate and future P/E experiencing only marginal adjustments, resulting in the consensus analyst price target holding firm at $19.05. What's in the News EPA granted Calumet full or partial exemptions on all small refinery petitions from 2019–2024, reducing RIN liability from 396 million to 89 million RINs. Calumet was added to numerous Russell indexes, including Russell 2000, 2500, 3000, and related growth/value/small cap completeness benchmarks, increasing its visibility to institutional investors.Narratiefupdate • Aug 25
Renewable Trends And Specialties Will Shape Future Markets
Despite a notable increase in consensus revenue growth forecasts for Calumet, a decline in net profit margin offset the improvement, resulting in an unchanged analyst price target of $19.05. What's in the News Calumet added to multiple Russell indices, including the Russell 2000, 2500, and 3000, as well as corresponding Growth and Value subsets.Narratiefupdate • Aug 10
Renewable Trends And Specialties Will Shape Future Markets
Despite materially improving revenue growth and net profit margin forecasts, Calumet’s consensus analyst price target remains unchanged at $18.80. What's in the News Calumet, Inc.Nieuw narratief • May 28
Sustainable Aviation Fuel Expansion Will Capture Future Market Opportunity
Accelerated renewables expansion and regulatory tailwinds drive higher margins, premium pricing, and stronger earnings outlook, particularly for sustainable aviation fuel and renewable diesel.Seeking Alpha • Apr 24
Calumet's Businesses Firing Like A Cannon, Well, Even Much Closer (Update)
Summary Calumet Specialty Products is significantly undervalued, with a misunderstood market and a heavy short position that is likely to face a destructive end soon. First-quarter EBITDA estimates are strong, with potential for $90 million, and second-quarter projections are even higher due to favorable market conditions. Management is effectively managing leverage and cash flow, aiming to reduce debt significantly while maintaining positive cash flow and strong EBITDA generation. Despite risks from shorting and market uncertainties, the company's strategic moves and financial performance suggest a bullish outlook, making it a compelling buy. Read the full article on Seeking AlphaSeeking Alpha • Mar 11
Calumet's Businesses Firing Like A Cannon, Well, Close
Summary Calumet delivered in-line Q4 2024 results, with management's asset sales and cash generation efforts creating a favorable buying opportunity. Specialty EBITDA is projected to improve to the low $200 million range in 2025, driven by stronger Gulf Coast 2-1-1 spreads and operational efficiencies. The partial sale of Performance Brands for $110 million will be offset by operational efficiencies, maintaining EBITDA levels over the next two years. Montana Renewables' cost structure improvements and strategic expansions position it as a low-cost producer, with significant cash flow contributions expected to support debt reduction and growth initiatives. Read the full article on Seeking AlphaAnalyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2026 | n/a | n/a | -US$137m |
| Mar 31 2026 | n/a | n/a | -US$189m |
| Dec 31 2025 | US$7m | US$950k | -US$34m |
| Sep 30 2025 | n/a | n/a | -US$37m |
| Jun 30 2025 | n/a | n/a | -US$451m |
| Mar 31 2025 | n/a | n/a | -US$343m |
| Dec 31 2024 | US$1m | US$784k | -US$222m |
| Sep 30 2024 | n/a | n/a | -US$230m |
| Jun 30 2024 | n/a | n/a | -US$30m |
| Mar 31 2024 | n/a | n/a | -US$12m |
| Dec 31 2023 | US$3m | US$735k | US$47m |
| Sep 30 2023 | n/a | n/a | US$20m |
| Jun 30 2023 | n/a | n/a | -US$65m |
| Mar 31 2023 | n/a | n/a | -US$58m |
| Dec 31 2022 | US$4m | US$569k | -US$170m |
| Sep 30 2022 | n/a | n/a | -US$179m |
| Jun 30 2022 | n/a | n/a | -US$143m |
| Mar 31 2022 | n/a | n/a | -US$205m |
| Dec 31 2021 | US$1m | US$334k | -US$255m |
Compensatie versus markt: De totale vergoeding ($USD 6.80M ) Louis } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 8.41M ).
Compensatie versus inkomsten: De vergoeding van Louis is gestegen terwijl het bedrijf verliesgevend is.
CEO
Louis Borgmann (43 yo)
2.2yrs
Tenure
US$6,799,276
Compensatie
Mr. Louis Todd Borgmann is President, Chief Executive Officer and Director at Calumet, Inc. since July 10, 2024. He was Director of Calumet GP, LLC at Calumet, Inc. and served as its Chief Executive Office...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 2.2yrs | US$6.80m | 0.30% $ 15.3m | |
| Executive VP & CFO | 2.7yrs | US$1.91m | 0.0028% $ 144.8k | |
| Senior VP | 14.4yrs | US$1.30m | 0.054% $ 2.8m | |
| Executive Vice President of Montana Renewables & Corporate Development | 5.6yrs | US$1.93m | 0.63% $ 31.9m | |
| President of Specialties | 6.7yrs | US$1.94m | 0.27% $ 13.8m | |
| Chief Accounting Officer | 1.3yrs | geen gegevens | 0.00063% $ 32.1k | |
| Director of Investor Relations | no data | geen gegevens | geen gegevens | |
| Alpha IR | no data | geen gegevens | geen gegevens |
4.1yrs
Gemiddelde duur
51.5yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van CLMT wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.1 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| President | 2.2yrs | US$6.80m | 0.30% $ 15.3m | |
| Independent Director | 1.3yrs | US$148.00k | 0.0080% $ 410.0k | |
| Lead Independent Director | 2.2yrs | US$258.38k | 0.015% $ 776.6k | |
| Independent Director | 2.2yrs | US$263.30k | 0.038% $ 1.9m | |
| Independent Director | 1.3yrs | US$146.25k | 0.0080% $ 410.0k | |
| Independent Director | 2.2yrs | US$282.33k | 0.033% $ 1.7m | |
| Chairman of the Board | 2.2yrs | US$475.83k | 0.35% $ 18.1m | |
| Independent Director | 2.2yrs | US$273.67k | 0.29% $ 15.0m | |
| Independent Director | 2.2yrs | US$248.75k | 0.093% $ 4.8m | |
| Independent Director | less than a year | geen gegevens | geen gegevens |
2.2yrs
Gemiddelde duur
66yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van CLMT wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 2.2 jaar), wat duidt op een nieuw bestuur.
Bedrijfsanalyse en status van financiële gegevens
| Gegevens | Laatst bijgewerkt (UTC-tijd) |
|---|---|
| Bedrijfsanalyse | 2026/09/17 02:57 |
| Aandelenkoers aan het einde van de dag | 2026/09/17 00:00 |
| Inkomsten | 2026/06/30 |
| Jaarlijkse inkomsten | 2025/12/31 |
Gegevensbronnen
De gegevens die gebruikt zijn in onze bedrijfsanalyse zijn afkomstig van S&P Global Market Intelligence LLC. De volgende gegevens worden gebruikt in ons analysemodel om dit rapport te genereren. De gegevens zijn genormaliseerd, waardoor er een vertraging kan optreden voordat de bron beschikbaar is.
| Pakket | Gegevens | Tijdframe | Voorbeeld Amerikaanse bron * |
|---|---|---|---|
| Financiële gegevens bedrijf | 10 jaar |
| |
| Consensus schattingen analisten | +3 jaar |
|
|
| Marktprijzen | 30 jaar |
| |
| Eigendom | 10 jaar |
| |
| Beheer | 10 jaar |
| |
| Belangrijkste ontwikkelingen | 10 jaar |
|
* Voorbeeld voor effecten uit de VS, voor niet-Amerikaanse effecten worden gelijkwaardige formulieren en bronnen gebruikt.
Tenzij anders vermeld zijn alle financiële gegevens gebaseerd op een jaarperiode, maar worden ze elk kwartaal bijgewerkt. Dit staat bekend als Trailing Twelve Month (TTM) of Last Twelve Month (LTM) gegevens. Meer informatie.
Analysemodel en Snowflake
Details van het analysamodel dat is gebruikt om dit rapport te genereren zijn beschikbaar op onze Github-pagina, we hebben ook handleidingen over hoe u onze rapporten kunt gebruiken en tutorials op YouTube.
Leer meer over het dat het Simply Wall St-analysemodel heeft ontworpen en gebouwd.
Industrie en sector
Onze industrie- en sectormetrics worden elke 6 uur berekend door Simply Wall St, details van ons proces zijn beschikbaar op Github.
Bronnen van analisten
Calumet, Inc. wordt gevolgd door 14 analisten. 6 van deze analisten hebben de schattingen van de omzet of winst ingediend die zijn gebruikt als input voor ons rapport. Inzendingen van analisten worden de hele dag door bijgewerkt.
| Analist | Instelling |
|---|---|
| Richard Gross | Barclays |
| Conor Fitzpatrick | BofA Global Research |
| Jennifer Fitzpatrick | BofA Global Research |